Daiichi Sankyo/Ranbaxy to integrate business operations in Thailand

Daiichi Sankyo and Ranbaxy Laboratories have reported their intention to integrate their business operations in Thailand, in a move which is expected to commence business on 1st April 2013. The planned integration of operations will provide a foundation for future Daiichi Sankyo group business expansion in Thailand, but will also be beneficial to Ranbaxy. It is expected to enhance the companies' competitiveness, whilst offering greater access to generics in Thailand. Under the plan, Daiichi Sankyo and Ranbaxy would integrate the management of Daiichi Sankyo's subsidiary in Thailand, Daiichi Sankyo (Thailand), and Ranbaxy’s Thailand subsidiary, Ranbaxy Unichem.

This article is tagged to:
Sector: Pharmaceuticals & Healthcare
Geography: India, Thailand, India, Japan, Thailand, Thailand

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.